Cargando…
Potential Drug Prediction of Glioblastoma Based on Drug Perturbation-Induced Gene Expression Signatures
OBJECTIVES: Glioblastoma (GBM) is a malignant brain tumor which is the most common and aggressive type of central nervous system cancer, with high morbidity and mortality. Despite lots of systematic studies on the molecular mechanism of glioblastoma, the pathogenesis is still unclear, and effective...
Autores principales: | Zhu, Bochi, Mao, Xijing, Man, Yuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857867/ https://www.ncbi.nlm.nih.gov/pubmed/33575336 http://dx.doi.org/10.1155/2021/6659701 |
Ejemplares similares
-
Perturbational Gene-Expression Signatures for Combinatorial Drug Discovery
por: Huang, Chen-Tsung, et al.
Publicado: (2019) -
Screening Potential Drugs for the Development of NAFLD Based on Drug Perturbation Gene Set
por: Gao, Zhengzheng, et al.
Publicado: (2022) -
Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures
por: Sawada, Ryusuke, et al.
Publicado: (2018) -
Predicting chemosensitivity using drug perturbed gene dynamics
por: Mannheimer, Joshua D., et al.
Publicado: (2021) -
Primary Sphenoidal Sinus Lymphoma with Initial Presentation as Unilateral Abducens Nerve Palsy Symptom
por: Mao, Xijing, et al.
Publicado: (2018)